M.J.T.M. Mol - Concepedia

Author

M.J.T.M. Mol

Radboud University Nijmegen

Also Known As

M J Mol, M J T M Mol, M Mol, M. J. T. M. MOL, M. J. T. M. Mol, M. J. Th. Mol, M. J.T.M. Mol, M. MOL, M. Mol, M.J. Mol

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen University of Amsterdam University of Groningen Radboud University Medical Center Canisius-Wilhelmina Ziekenhuis

About

M.J.T.M. Mol is an author at Radboud University Nijmegen specializing in medicine, atherosclerosis, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	627
2	Health Sciences	5	5	284
3	Biochemistry	3	3	196
4	Public Health	1	1	82
5	Applied Physiology	1	1	23

M.J.T.M. Mol

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
EFFECTS OF SYNVINOLIN (MK-733) ON PLASMA LIPIDS IN FAMILIAL HYPERCHOLESTEROLAEMIA M.J.T.M. Mol, J.A. Gevers Leuven, D.W. Erkelens, The Lancet Metabolic SyndromeLipid DisorderEffects Of SynvinolinBiochemistryHyperlipidemia	1986	156
Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment M.J.T.M. Mol, Yolanda B. de Rijke, Pierre N.M. Demacker, Atherosclerosis Cholesterol Oxidation ProductsMetabolic SyndromeNutritionLipid PeroxidationPhysiology	1997	130
Enhanced Levels of Lipoperoxides in Low Density Lipoprotein Incubated with Murine Fibroblasts Expressing High Levels of Human 15-Lipoxygenase D. Benz, M.J.T.M. Mol, Masanori Ezaki, Journal of Biological Chemistry	1995	107
Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice. Bart J. van Vlijmen, H. Belinda van 't Hof, M.J.T.M. Mol, Journal of Clinical Investigation Apolipoprotein E3-leidenGeneticsHyperlipidemiaOxidative StressMetabolic Syndrome	1996	92
Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia Peter De Kniiff, Anton F. H. Stalenhoef, M.J.T.M. Mol, Atherosclerosis Lipid DisorderHeterozygous Familial HypercholesterolemiaCardiovascular DiseaseGenetic EpidemiologyHuman Polymorphism	1990	82
Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemia M.J.T.M. Mol, D. Willem Erkelens, J.A. Gevers Leuven, Atherosclerosis Metabolic SyndromeLipid DisorderHeterozygous Familial HypercholesterolaemiaOxysterolCardiovascular Disease	1988	79
Topical calcitriol in the treatment of chronic plaque psoriasis: a double-blind study Andrzej Langner, H Verjans, V Stapór, British Journal of Dermatology OphthalmologyPharmacologyTopical CalcitriolPsoriatic ArthritisDouble-blind Study	1993	62
Web-based cognitive behavioural therapy blended with face-to-face sessions for chronic fatigue in type 1 diabetes: a multicentre randomised controlled trial Juliane Menting, Cees J. Tack, Arianne C. van Bon, The Lancet Diabetes & Endocrinology Type 1Diabetes ManagementMental Health MonitoringAssistive TechnologyPsychiatry	2017	59
Both Lipolysis and Hepatic Uptake of VLDL Are Impaired in Transgenic Mice Coexpressing Human Apolipoprotein E*3Leiden and Human Apolipoprotein C1 Miek C. Jong, Vivian E.H. Dahlmans, Patrick J. van Gorp, Arteriosclerosis Thrombosis and Vascular Biology	1996	58
EFFECTS OF INHIBITION OF CHOLESTEROL SYNTHESIS BY SIMVASTATIN ON THE PRODUCTION OF ADRENOCORTICAL STEROID HORMONES AND ACTH M.J.T.M. Mol, Anton F. H. Stalenhoef, P.M.J. Stuyt, Clinical Endocrinology	1989	29

Page 1